2022
9
US Managing Common Illness Market Report 2022
2022-05-03T04:01:28+01:00
OX1101697
3695
150926
[{"name":"Healthcare and Medical","url":"https:\/\/store.mintel.com\/industries\/health-wellbeing\/healthcare-medical"}]
Report
en_GB
“The COVID-19 pandemic changed the way that consumers approach managing common illness. While consumers still rely on traditional OTC cough, cold, and flu remedies to treat symptoms of common illness,…

US Managing Common Illness Market Report 2022

£ 3,695 (Excl.Tax)

Description

“The COVID-19 pandemic changed the way that consumers approach managing common illness. While consumers still rely on traditional OTC cough, cold, and flu remedies to treat symptoms of common illness, they have also begun to look for immune-boosting ingredients in an effort to prevent future illness. As consumers return to normal activities, they have increased exposure to common illness germs at levels they aren’t accustomed to, resulting in a more active common illness season. Traditional OTC brands must focus on remedies that not only address shared symptoms of common illness, including COVID-19 but also account for changing consumer needs by offering products that prevent common illness and strengthen the immune system.”
– Dorothy Kotscha, Health Analyst

This Report looks at the following areas:

  • The re-emergence of common illness as COVID-19 mandates are largely relaxed
  • How the approach to managing common illness has changed as pandemic era habits have been adopted into daily life
  • Consumer interest in technology-based tools to help track individual symptoms and community spread of future common illness
  • Vaccine motivations, reasons for hesitancy and what it means for treating future common illness

Table of Contents

  1. Overview

    • What you need to know
    • This Report looks at the following areas
    • Definition
    • Market context
  2. Executive Summary

    • Top takeaways
    • Market overview
      • Figure 1: Total US sales and fan chart forecast of market, at current prices, 2016-26
      • Figure 2: Category outlook, 2022-27
    • Opportunities and challenges
    • Consumers most often manage their common illness symptoms with OTC remedies
      • Figure 3: Correspondence Analysis – Symmetrical map – Managing common illness, 2022
    • Most consumers rely on traditional formats of OTC remedies
      • Figure 4: TURF analysis – Treatment solutions, 2022
    • Consumers look for ways to incorporate digital tools to meet their health needs
      • Figure 4: Interest in future tech usage for illness management, 2022
    • OTC herbal remedies see sales declines as consumers look for traditional active ingredients
      • Figure 5: Interest in OTC remedies with herbal ingredients, 2022
    • Key consumer insights
  3. Market Size and Forecast

    • Market sales rebound as consumers resume normal levels of activity
      • Figure 6: Total US sales and fan chart forecast of market, at current prices, 2016-26
      • Figure 7: Total US sales and forecast of market, at current prices, 2016-26
  4. Segment Performance

    • Common illness segment remains steady, allergy segment sees accelerated growth
      • Figure 8: Total US retail sales and forecast of cold, cough, flu and allergy remedies, by segment, at current prices, 2016-26
    • Sales continue to increase in “other” channels
      • Figure 9: Total US retail sales of cold, cough, flu and allergy remedies, by channel, at current prices, 2016-21
  5. Market Factors

    • Increasingly diverse population requires better representation
      • Figure 10: Population by race and Hispanic origin, 2016-26
    • Unusually low flu burden means less demand for OTC remedies
    • Climate change impacts seasonal allergies
      • Figure 11: Asthma and Allergy Foundation of America Instagram post, 2022
    • Face mask usage remains in limbo as COVID-19 restrictions ease
      • Figure 12: Multi-outlet sales of face masks and face shields, at current prices, 2016-26
  6. Market Share

    • OTC remedy companies bounce back as consumers resume normal activities
    • Sales of cough, cold, flu and allergy remedies by company
      • Figure 13: Multi-outlet sales of cough/cold/flu and allergy remedies, by leading companies, rolling 52 weeks 2021 and 2022
    • Cough, cold and flu remedies experience double digit growth
      • Figure 14: Multi-outlet sales of cough/cold/flu remedies, by leading companies and brands, rolling 52 weeks 2021 and 2022
    • Allergy segment sees sustained gains, boosts category growth
      • Figure 15: Multi-outlet sales of allergy remedies, by leading companies and brands, rolling 52 weeks 2021 and 2022
  7. Competitive Strategies and Market Opportunities

    • Create OTC COVID-19 remedies to help manage symptoms of COVID-19 at home
    • Incorporate immune boosting ingredients in existing OTC remedies
      • Figure 16: Zarbee’s Cough Syrup + Mucus & Immune Natural Berry Flavor Dietary Supplement, 2020
    • Pharmaceutical brands emphasize a “return to what you love” in ad campaigns
      • Figure 17: Google Instagram post 2021
    • Utilize technology to help consumers manage future common illness
  8. The Common Illness Consumer – Fast Facts

  9. Common Illness Experienced

    • Consumers see a rise in almost all common illness symptoms
      • Figure 18: Common illness and symptoms experienced in the past year, 2021-22
    • Consumers feel the effects of longer allergy seasons
      • Figure 19: Xyzal Allergy 24HR Tablets, 2021
    • Parents report a wide range of ailments as their exposure increases
      • Figure 15: Common illness and symptoms experienced in the past year, by parental status, 2022
    • Young women report higher incidence of common illness
      • Figure 20: Common illness and symptoms experienced in the past year, by gender and age, 2022
  10. Managing Symptoms of Common Illness

    • OTC remedies are the first line of defense
      • Figure 21: Managing symptoms of common illness, 2022
  11. Preventative Measures

    • Consumers implement range of prevention strategies to avoid common illness
      • Figure 22: Methods used to prevent common illness, 2022
    • Asian consumers report highest incidence of mask wearing and social distancing
      • Figure 23: Methods used to prevent common illness, by race and Hispanic origin, 2022
    • Multigenerational families may be at higher risk of common illness
      • Figure 24: Select methods used to prevent common illness, by number of generations in household, 2022
  12. OTC Remedy Usage

    • OTC remedies remain the go-to for managing common illness
      • Figure 25: OTC remedy usage to manage common illness, 2022
      • Figure 26: Mucinex US Instagram post, 2021
      • Figure 27: OTC remedy usage to manage common illness, by year 2021-22
    • Asian consumers rely more heavily on herbal remedies
      • Figure 28: OTC remedy usage to manage common illness, by race, 2022
    • Millennials employ a broader strategy to manage common illness
      • Figure 29: OTC remedy usage to manage common illness, by generation, 2022
  13. Attitudes toward Preventing Future Illness

    • Consumers remain focused on prevention
      • Figure 30: Interest in future illness management methods, 2022
    • Adults aged 25-44 drive interest in tech-based management solutions
      • Figure 31: Interest in technology to manage future illness, by age, 2022
    • Continued masking is met with mixed feeling
      • Figure 32: Interest in face masks to manage future illness, by gender and generation, 2022
  14. Vaccination Incidence

    • COVID-19 viewed in similar light as the seasonal flu
      • Figure 33: Vaccine incidence for flu and COVID-19, 2022
    • Low-income families are more reluctant to vaccinate
      • Figure 34: Vaccine incidence for flu and COVID-19, by income 2022
    • Vaccine rates among Black and Hispanic consumers remains low
      • Figure 35: Vaccine incidence for flu and COVID-19, by race and Hispanic origin, 2022
    • Younger adults may need a ‘final push’ for vaccine
      • Figure 36: Vaccine incidence for flu and COVID-19, by age 2022
  15. Motivations for Receiving the COVID-19 Vaccine

    • Most consumers heed the CDC’s advice on vaccinating
      • Figure 37: Motivations for getting the COVID-19 vaccine, 2022
    • Vaccines prove to be effective, and consumers are ready to get back to normal life
      • Figure 38: Motivations for getting the COVID-19 vaccine, 2021-22
    • Gen Z motivated to get back to normal life
      • Figure 39: Motivations for getting the COVID-19 vaccine, Gen Z by gender, 2022
  16. Reasons for COVID-19 Vaccine Hesitancy

    • Consumers are apprehensive about side effects and effectiveness
      • Figure 40: Reasons for not getting the COVID-19 vaccine, 2022
  17. Impact of COVID-19 on Illness Perceptions

    • A wide array of COVID-19 symptoms makes it difficult to differentiate
      • Figure 41: Impact of COVID-19 on managing common illness, 2022
    • Asian consumers worry about getting sick around others
      • Figure 42: Impact of COVID-19 on managing common illness, by race and Hispanic origin, 2022
    • Lower income households carry emotional burden of getting sick
      • Figure 43: Impact of COVID-19 on managing common illness, by income 2022
  18. Appendix – Data Sources and Abbreviations

    • Data sources
    • Sales data
    • Forecast
    • Consumer survey data
    • Abbreviations and terms
    • Abbreviations
  19. Appendix – The Market

      • Figure 44: Total US retail sales and forecast of cold, cough, flu and allergy remedies, at inflation-adjusted prices, 2016-26
      • Figure 45: Average annual household spending on cold, cough, flu and allergy remedies, 2016-21
      • Figure 46: Total US retail sales of cold, cough, flu and allergy remedies, by segment, at current prices, 2019 and 2021
      • Figure 47: Total US retail sales and forecast of cough/cold/flu remedies, at inflation-adjusted prices, 2016-26
      • Figure 48: Total US retail sales and forecast of allergy remedies, at inflation-adjusted prices, 2016-26
      • Figure 49: US supermarket sales of cold, cough, flu and allergy remedies, at current prices, 2016-21
      • Figure 50: US drugstore sales of cold, cough, flu and allergy remedies, at current prices, 2016-21
      • Figure 51: US sales of cold, cough, flu and allergy remedies through other retail channels, at current prices, 2016-21
      • Figure 52: Table – TURF Analysis – Treatment solutions, 2022
    • Methodology
      • Figure 53: Managing common illness, 2022
    • Methodology

About the report

This market report provides in-depth analysis and insight supported by a range of data. At the same time, introductory and top-level content is provided to give you an overview of the issues covered.

Market

Mintel provides a range of market information, frequently through the category level, including market size and forecasting, complete with market drivers that illustrate the forces that shape a category or market.

Consumer

Mintel’s proprietary consumer research provides our analysts with the attitudinal and behavioral data used to provide valuable insight to topical issues.

Brand/Company

Mintel provides overviews of the top brands and manufacturers, and uses consumer research to explore attitudes and reactions to brands, as well as insight into what will resonate with consumers.

Data

Market reports provide appendices of data to support the research and insight produced. Our databooks* are easily manipulated and downloadable to support your research needs and covers factors from consumer attitudes to market forecasts.

*databooks not available with UK B2B Industry reports.

Below is a sample report, understand what you are buying.

Click to show report
2024 Sample Consumer Cover

Please Note: This is a sample report. All of the figures, graphs, and tables have been redacted. Our reports are available to download in PDF and PPT formats.

Trusted by companies. Big and small.

Want to speak to us directly?

Contact us with your enquiry and our expert global team can help.

Get in touch